CVS Group plc, a leading provider of integrated veterinary services in the UK, has released a notification regarding its existing block listing arrangements. This notification is in accordance with Schedule Six of the AIM Rules for Companies and pertains to the Company's ordinary shares of 0.2 pence each ("Ordinary Shares").

The relevant schemes for which the notification is made are the CVS Group SAYE Plan and the CVS Long Term Incentive Plan. The period of return for this notification spans from January 12, 2024, to July 12, 2024. The balance of unallotted securities under the schemes from the previous return is detailed as 392,455 for the CVS Group SAYE Plan and 68,393 for the CVS Long Term Incentive Plan.

During the specified period, 48,148 securities were issued/allotted under the CVS Group SAYE Plan, resulting in a balance of 344,307 securities not yet issued/allotted at the end of the period. No increase has been applied for in the block scheme(s) since the date of the last return. The number and class of securities originally listed, along with the date of admission, are 350,000 Ordinary Shares admitted on December 30, 2021, and 120,000 Ordinary Shares admitted on May 15, 2023.

The company's contacts for further information are provided, including CVS Group plc, Peel Hunt LLP (Nominated Adviser & Broker), Berenberg (Joint Broker), and Camarco (Financial PR).

This notification provides transparency and insight into CVS Group plc's block listing arrangements and the status of its relevant schemes, offering stakeholders and investors a comprehensive overview of the company's securities and incentive plans.